DERMATOFIBROSARCOMA PROTUBERANS --A RARE VARI^ANTOF
SOFT TISSUE SARCOMA OF SKIN. AN EXPERIENCE OF TWO CASES
AT AYUB TEACHING HOSPITAL COMPLEX (ATHC), ABBOTTABAD
Tariq Mufti*, M. Saeed Khan**, Muzher-U-Dua and Farah-Waqar
Department of *Surgery and Oncology Ayub Teaching Hospital and **Institute of Nuclear Medicine Oncology and
Radiotherapy (INOR)
(For extreme disease, extreme method of cure)
CASE:1
An old lady of 58 years’ age presented with a huge soft
tissue mass over left pectoral region which was
gradually increasing in size over the last 5-ycars.
Patient also gives history' of recent appearance of
constant dull pain and low grade fever (<100Fo) for the
last 3-4 months. CT Scan revealed a soil tissue sub
cutaneous mass extending from the dermis downwards
without rib erosion. X-Ray chest clear and USG
abdomen was normal. Excisional biopsy revealed
Dermatofibrosarcoma protuberans. After wound
healing, external radiation on 10Mev electron beam
(Varianclinac-20) with direct anterior field
encompassing nearly upper 2/3 of left chest wall and
delivering a tumor dose of 48 grays at I cm depth in 16
treatments. 3 ’A weeks’ time as ϵ 300 cgys daily.
diameter and over lying skin of normal colour. Accessible
lymph nodes were not palpable, fiver and spleen were not
palpable. C.T scan of thigh revealed a soft tissue s/c mass
with increased vascularity without involvement of
underlying bone (femur). Ultrasonography abdomen was
normal and x-ray chest clear. Excisional biopsy revealed
Dermatofibrosarcoma protuberans. External radiation was
planned on cobolt 60 with lateral opposing fields to midline
dose of 60 grays in 30 fractions for 6 weeks’ time.
The tumor bed can be radiated on cobolt -60 (Mega
voltage beam) with tangential fields to mid line dose
of 60 grays in 30 fractions for 6 weeks’ time (if facility
of linac is not available).
Fig – 2 CT Scan Showing Soft tissue distortion (Case – II)
Fig-1 X-Ray of thigh showing soft tissue mass (case II)
CASE-2
A middle age women of 40 years, presented with
painless soft tissue swelling over antero-lateral aspect
of upper 3rd of left thigh with gradual increase in size
for the last 3 ½ year. On examination there was a firm,
non-tender, hardly mobile (from side to side) soft
tissue mass measuring approx. 5cm in its greater
Fig – 3 CT Scan Showing Soft tissue distortion (Case – II)
32
DISCUSSION
Dermatofibrosarcoma Protuberans (l)ISP) is an
uncommon locally malignant slowly growing tumor
originating in the dermis from fibroblast and
histogenecally linked to histiocytes and labeled as
malignant fibroblastic histiocytoma of the skin 2,13 12.
It appears clinically as small indurated dark red colour
firm nodule or fibrous plaque on one side of midline
usually on trunk and proximal extremities and rarely
on head and neck region4567. Patients are usually
middle aged complaining of a firm painless lump
(nodule) in the skin that has been slowly increasing in
size for several years. These lesions remain intracutaneous until the plaques coalesce and begin to grow
rapidly and if left untreated the skin surface become
ulcerated with a fun gating neoplasm. Males are
effected 'more than females (4:1) and it is commoner
in blacks than whites8.
beyond the site of origin makes the use of adjuvant
radiation therapy particularly appealing.
Radiotherapy can be applied pre-operatively. intraoperative by and postoperative by25 26 Experience with
pre-operative radiation therapy is limited because the
radiation therapist usually does not see these patients
until after a surgical resection has been performed.
Local control can be achieved in > 85% cases treated
post operatively to doses in the range of 60-65 grays
in 6- 7 wks time with satisfactory functional results.
Local failure following postoperative radiation
therapy is rare in patients with limited size lesion
(stage-1 & II ), there may be increased risk of local
recurrence when doses < 50 grays arc utilized.
Kiel & Suit have suggested doses >. 60 grays may be
associated with greater chance of local control" but we
have generally used in our practice doses of 55-60
grays with encouraging results. Patients with inoperable or un-resectable tumors have been treated
with external beams o i/v radio sensitizers with good
palliations28. Local control is quite respectable in
patients with small lesion adequately' treated to full
tumoricidal doses of radiation 2 9 but it remains
essential to remove the tumor with a margin of normal
tissue.
Surgical treatment is associated with frequent local
recurrence (over 5o%) and in many ways this tumor
behaves like desmoid except that distant metastasis
occasionally occur (5%)9,10,7. Although, some authors
labelled DFSP as benign, its loco-regional behaviour
is truly malignant. Treatment should be aggressive and
include wide resection followed by post-operative
radiation11.
Microscopically it is a highly cellular lesion difficult
to differentiate from sub-cutaneous fibrosarcoma12
that occurs most commonly as non-specific nodules on
extremities with normal skin overlying. Pigment laden
cells may occur and these lesions predominantly affect
persons of colour called “Bednar tumors”13,14
The arguments for pre-operative radiation therapy
include:
That pre-operative treatment produces partial
regression of the tumor resulting in less extensive
surgical resection.
i.
Electron microscopic studies favour a neurofibroblastic origin and tissue culture experiments
surest histiocytic origin 5,6. Many general surgeons
lack experience in the management of DFSP and this
probably accounts for the performance of sub- optimal
surgical procedure in many patients especially at DHQ
Hospitals. Even in teaching hospitals, the routine
practice is simple excision (enucleation). This
procedure involves removal of the gross tumor with
the Pseudo-capsule where microscopic extension
remains in-Situ and tissue planes are often
contaminated by the procedure and the resulting
Hameatoma. By itself this procedure is inadequate
therapeutically and almost always results in local
recurrence17,18 in patients in whom even, extensive
surgical procedures including Mohs surgery result in
sub-optimal margin of resection 19, 14.
It may decrease the risk of auto
transplantation of the tumor in the surgical bed and of
intravascular seeding.
ii.
Atkinson and associates’0 reported excellent local
control following moderate doses 45- 50 grays in.4-5
weeks’ time and block resection. Martin and coworkers have reported similar results in patients with
advanced lesions treated with 50-70 grays preoperatively. Suit et a/., showed an actual local control
rate of 89% at 5 years 32,34 McNeer et al. (Memorial
Hospital NYC) reported 57 % 5 years’ survival with
adjuvant
radiation
therapy35.
Pre-operative
radiotherapy plus hyperthermia may also have
promise.36
Many surgeons and radiotherapists favour postoperative treatment. Post-operative radiotherapy must
be delayed until adequate wound healing has occurred.
Adjuvant radiation therapy may improve local tumor
control and eradicate sub-clinical (microscopic)
disease. The tendency of DFSP to permeate deep into
the subcutaneous tissue far
CONCLUSION
It has become clear that in most patient’s radical
surgery resulting in mutilation can be obviated by the
judicious use of adjuvant radiotherapy. The optimal
combined modality approach is still under
investigation.
33
17. Cantin J, Meneer JP. Chu PC el al the problem of
local recurrence after surgical excision ann. Surg
1968 168.47
18. Schieber W. Grham P: an experience with sarcoma
tissue in adults Surgery 1962 52 295
19. Albright SIT treatment of skin cancer using
multiple modalities J Am Acad Dermatol 1982 7
143
20. Hruza GJ Mohs micro graph surgery, oto larygol
Clin. North Am 1990 23 845
21. Mohs FE & Blanchard L Microscopically
controlled for extra memory pajet's disease arch
Dermatol 1979 115. 706
22. Rowe DE. Carroll RJ, Dayel long term the
recurrence rate in previously untreated skin cancer
J. Dermatol Surg Oncol 1989 15:315
23. Radnar D et al. Mohs micrographic surgery for the
treatment of DFSP J. Am. Acad Dermatol 1997 37
600.
24. Robinson J: DFSP resected by mohs surgery. J Am.
Acad Dermatol 1985. 12:1093
25. Suit HD. Mankein HJ, wood WO. Props KM. Preoperative, intra operative & post-operative
radiation in the treatment of soft tissue sarcoma.
Cancer. 1985 55: 2659-26667.
26. Tepper JE, Suit HD. The role of radiotherapy in
soft tissue sarcoma. Cancer invest 1985 3: 587592.
27. Kiel KD, Suit HD Radiation therapy in the
treatment of aggressive fibromatosis (desmoid
tumors). Cancer 1985 54. 2041-2055.
28. Kinsella TJ, Glastein E. Clinical experience with
i/v radio sanitizers in unresectable sarcoma. Cancer
1987 59 908-915.
29. Tepper JE, suit HB. radiation therapy alone for
soft tissue sarcoma. Cancer 1985 56: 475.
30. Atkin L, Garvan Jm. Neuton NT. behaviour and
management of soft tissue sarcoma. Cancer 1963
60: 1552
31. Martin RG. Lindberg RD, Russel WO. Preoperative radiotherapy & surgery in the
management of soft tissue and bone sarcoma. PB
299-307 Chicago year book medical publishers
1977.
32. Rosenberg SA. suit HD baker LH et al. Soft tissue
and bone sarcoma in Devita. cancer principle and
practice of oncology. Philadelphia Lippin cortt
1982 pp 1036-1068.
33. Suit HD proppe KH: Multi-disciplinary decisions
in oncology. Soft tissue sarcoma. New York
Pergoman press 1982.
34. Suit HD. Proppe KH, Mankin HJ et al: Preoperative radiotherapy for soft tissue sarcoma.
Cancer 1981 47: 2267- 2774.
35. Meneer GP, cantin J, Chu F et al: Effective of
radiotherapy for soft tissue sarcoma. Cancer 1968.
22;391 -397
36. Mittal D, Emami B. Sapareto S et al., Effects of
combined hyperthermia and radiation on the RIF-1
murine tumor. Cancer 1984 54:2889.
37. Raney B, Jr.: Soft tissue sarcoma in
adolescent in tibbi CK (ed). Major topics in
adolescent oncology) Mamt Kisco, Future
publishing 1987 PP 221 -240
The extent of surgical procedure, timing and adequate
doses of radiation, use of Electron beam of varying
penetration, sparing of medial or literal strip of tissue
to provide lymphatic drainage in the extremity and
proper selection of treatment aids such as beam
shaping blocks, tissue equivalent bolus, missing tissue
compensator and wedge filters for beam hardening and
immobilization devices for patients positioning are not
only essential but highly desirable and must be defined
more precisely.
Several randomised trials have shown no benefit to
chemotherapy in these tumors and its potential value
must be weighed against the significant toxicity.
REFERENCES
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
Hippocrates The theory and practice of medicine.
Runes DD. Kleman T(eds) Secaucus NJ, Citadel
press 1964
Gloster HM JR..DFSP. J Am. Acad. Dermatol
1996; 35:355
Gutierrez G. DFSP. Inj. J. Dermatol. 1984; 23:396
Alguacil Garcia A and Go liner JR. Histogenesis of
DFSP an ultra-structural study. Am J Clin. Pathol.
1978 69:427
Eilber FR, Morton Dl and Econoomon JS. The soft
tissue sarcomas, Orlando FL & New York. 1987.
Fletcher CD, Evans BJ, Mekee PH. DFSP. A
clinic-pathological and immuno-histochemical!
study, a review of literature. Histopathology
1985:9: 921.
Taylor HB. Helwig EB. DFSP A study of II5 cases.
Cancer. 1962.15; 717.
Garg SK, Subbuswamy SG, Lawrie JH. DFSP in
northern Nigeria. A clinicopathoiogical review of
17 cases. Clin Oncol 1978;4: 113.
. Burkhardt BR, Soule EH, Wink Elman RK et al.
DFSP. A study of 56 cases. Am J. Surg. 1966. 11;
638
Mcpeak CJ, Druz T, Nicestri AD. DFSP. An
analysis of 86 cases, 5 with metastasis. Ann. Surg.
1967 166; 803.
Rink PA, Habermalz HJ, Loccek H: Effective
radiotherapy in one case of DFSP Starling
Therapies. 1982 158:681.
Hajdu SI: Pathology of soft tissue sarcoma.
Philadelphia Lea and Febiger. 1979.
Kobayashi T el al: a case of Bednar tumor.
dermatology. 1997.195:87.
Eigen GW et al: Bednar tumor occurring in site of
prior immunization. J. Am. Acadmi. Dermatol
1999.40:315.
Hashimoto K, Brownstein Mh Jsceobi FA: DFSP.
Arch. Dermatol 1974 110:874.
Qzzello L & Hamel SJ: the histolytic nature of
DFSP. Tissue culture and electron microscopic
study Am J Clin Pathol 1976 65:136
34